On April 20, 2015, the Supreme Court heard Sanofi-Aventis’ appeal of the Federal Court of Appeal section 8 quantification decision with respect to the drug Ramipril.
April 29, 2015
Prothonotary Lafrenière issued an order pursuant to section 6(5)(b) of the PM(NOC) Regulations striking all allegations relating to one of three patents.
April 16, 2015
Bill C-17, An Act to Amend the Food and Drugs Act (also referred to as the Protecting Canadians from Unsafe Drugs Act), received Royal Assent on November 6, 2014.
April 15, 2015
Janssen Inc [Janssen] sells infliximab under the brand name REMICADE®.
April 09, 2015
Insurers, like all businesses operating in Europe, are subject to European and domestic data protection laws.
April 08, 2015
On March 18, 2015 the Canadian Intellectual Property Office (“CIPO”) issued a Patent Notice: Revised Examination Practice Respecting Medical Uses (the “Notice”).
March 31, 2015
On 26 February 2015, the UK Government published its response to the Law Commission’s proposed reforms to the groundless threats of intellectual property right infri
March 27, 2015
On March 16, 2015, Justice Barnes of the Federal Court issued his decision in AstraZeneca Canada Inc. et al v. Apotex Inc., 2015 FC 322.
March 24, 2015
South Africa remains the international gateway to the rest of Africa and the ports of Durban, Richards Bay and Saldanha Bay remain the busiest on the continent.
March 19, 2015
This case is the most recent in a small line of cases concerning the intellectual property implications, or lack thereof.
March 11, 2015
Try searching our global site instead